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Infections caused by antibiotic-resistant bacteria are a major threat to public health. 12 
The pathogens causing these infections can acquire antibiotic resistance genes in a 13 
process termed horizontal gene transfer (HGT). HGT is a common event in the 14 
human gut microbiome, i.e. the microbial ecosystem of the human intestinal tract. 15 
HGT in the gut microbiome can occur via different mechanisms of which transduction 16 
and conjugation have been best characterised. Novel bioinformatic tools and 17 
experimental approaches have been developed to determine the association of 18 
antibiotic resistance genes with their microbial hosts and to quantify the extent of 19 
HGT in the gut microbiome. Insights from studies into HGT in the gut microbiome 20 
may lead to the development of novel interventions to minimise the spread of 21 




- The human gut microbiome harbours antibiotic resistance genes (‘the 25 
resistome’) 26 
- Antibiotic resistance genes can spread in the gut microbiome through 27 
horizontal gene transfer (HGT) 28 
- The best characterised mechanisms of HGT in the human gut microbiome are 29 
transduction and conjugation  30 
- Novel bioinformatic and experimental approaches have been developed to 31 
study HGT in the gut  32 
3 
The human gut microbiome and antimicrobial resistance 33 
The term ‘human gut microbiome’ describes the microorganisms, their genomes and 34 
the environmental conditions of the human intestinal tract [1]. Over the last decade, 35 
the implementation of high-throughput, low-cost sequencing methods has fuelled 36 
research into the gut microbiome, with the aim to uncover its composition, function, 37 
and role in health and disease [2]. The gut contains hundreds of bacterial species, 38 
collectively called the microbiota, with those belonging to the phyla Bacteroidetes 39 
and Firmicutes accounting for 90% of all species in the gut of healthy adults [3]. The 40 
phyla Actinobacteria, Proteobacteria, Fusobacteria and Verrucomicrobia are 41 
generally less abundant, but can contribute to important functions, such as providing 42 
protection against invading pathogens [4,5]. Most gut bacteria have a symbiotic or 43 
commensal relationship with the human host. However, the gut microbiota also 44 
contains opportunistic pathogens, including those belonging to the families 45 
Enterobacteriaceae, particularly Escherichia coli and Klebsiella pneumoniae, and 46 
Enterococcaceae, most notably Enterococcus faecalis and Enterococcus faecium. 47 
Intestinal carriage of opportunistic pathogens can predispose an individual to urinary 48 
tract infections and, in immunocompromised patients, more serious systemic 49 
infections [6–8]. Recent decades have seen a global rise of infections caused by 50 
antibiotic-resistant clones of E. coli, K. pneumoniae [9], and E. faecium [10].  51 
Infections caused by antibiotic-resistant bacteria are a significant threat to global 52 
public health. The annual attributable mortality due to antibiotic-resistant infections in 53 
the EU alone is estimated to number over 30,000 deaths, with the highest cases 54 
occurring in Italy and Greece [11]. Morbidity and mortality due to multi-drug resistant 55 
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infections are even higher in low- and middle-income countries in Asia, Africa and 56 
South America  [12–14].  57 
The main mechanisms by which bacteria can become resistant to antibiotics are 58 
prevention of the antibiotic from reaching toxic levels inside the cell, modification of 59 
the antibiotic target, and modification or degradation of the antibiotic itself [15]. 60 
These resistance mechanisms can arise through mutations of chromosomal genes 61 
and the acquisition of antibiotic resistance genes (ARGs) from other strains of the 62 
same, or different, species in a process termed horizontal gene transfer (HGT). The 63 
sharing of genes through HGT contributes importantly to the global dissemination of 64 
ARGs [16]. HGT can occur in any environment, particularly when bacterial loads are 65 
high, e.g. in soil [17], in wastewater treatment plants [18,19] and in the gut 66 
microbiome of humans and animals [20–22]. 67 
As E. coli, K. pneumoniae, C. difficile, enterococci and other opportunistic pathogens 68 
inhabit the human gut, there is a distinct possibility that they can acquire resistance 69 
determinants from other members of the gut microbiota. Indeed, previous work has 70 
shown that the gut harbours many and diverse antibiotic resistance determinants, 71 
which have collectively been termed the ‘gut resistome’ [23,24]. In this review, we 72 
will provide an overview of the different mechanisms of HGT in the human gut 73 
microbiome and of innovative methods to study HGT in this microbial ecosystem. 74 
 75 
Mechanisms of horizontal gene transfer 76 
ARGs can be horizontally transferred through a number of mechanisms, the most 77 
important of which are transformation, transduction, and conjugation. More recently, 78 
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the role of membrane vesicles (MVs) in HGT has also been recognised. In this 79 
section, we will shortly discuss the relevance of these HGT mechanisms in the 80 
context of the spread of ARGs in the gut microbiome (Figure 1).  81 
In transformation, naked DNA from the extracellular environment is taken up by 82 
bacteria and inserted into their genomes. The process of transformation requires 83 
bacteria to be naturally transformable or competent. Over 80 bacterial species have 84 
been experimentally proven to be naturally competent, and the presence of genes 85 
involved in DNA uptake in a number of other species suggests that this trait is more 86 
widespread [25]. The stimuli that lead to a competent state in naturally transformable 87 
bacteria are only partially understood, but nutrient starvation and the presence of 88 
competence-inducing peptides have been identified as triggers [26]. Important 89 
pathogens, including Neisseria gonorrhoeae, Vibrio cholerae, and Streptococcus 90 
pneumoniae are naturally competent pathogens and have acquired antibiotic 91 
resistance through this process [27]. While DNAse activity in the gut will degrade 92 
most DNA [28], intact plasmid DNA can be isolated from the gut contents of rats that 93 
are fed plasmids [29]. This finding indicates that there is potential for extracellular 94 
DNA to be taken up by naturally competent bacteria. Observations showing that E. 95 
coli can be transformed by plasmid DNA under natural conditions [30,31], suggest 96 
that E. coli could take up DNA in the gut, with transformation thus conceivably 97 
contributing to the spread of ARGs. The extent by which DNA can spread 98 
horizontally in the gut through the process of transformation is, however, currently 99 
unknown.  100 
MVs Membrane vesicles (MVs) are 20–250 nm spherical structures that are 101 
predominantly produced by Gram-negative bacteria when the outer membrane 102 
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bulges away from the cell and is then released through constriction [32]. MVs fuse 103 
with their target cells, thus delivering their cargo. MVs that are produced in vitro by 104 
the gut commensal Bacteroides can contain β-lactamases and these vesicles protect 105 
target cells against β-lactam antibiotics [33]. In the context of HGT, it is relevant that 106 
MVs produced by gut bacteria can also contain cytoplasmic contents, including DNA 107 
[34]. DNA-containing MVs are thought to be formed by protrusion of both the outer 108 
and inner membrane, which leads to the inclusion of cytoplasmic components into 109 
the vesicles [35]. Indeed, membrane vesicles isolated from bacteria in the genus 110 
Acinetobacter can transfer antibiotic resistance plasmids in vitro [36]. Similarly, 111 
vesicle-mediated transfer of DNA has also been reported for E. coli [37]. While MVs 112 
are produced in the gut and can potentially influence host immune responses [38], it 113 
is as yet not clear whether they can also contribute to HGT in the gut microbiome.   114 
Transduction describes the transfer of chromosomal and extrachromosomal DNA 115 
between bacteria via a viral intermediate known as a bacteriophage. The main 116 
mechanisms of transduction are generalised transduction, specialised transduction, 117 
and lateral transduction. Collectively these can cause the mobilisation of any 118 
fragment of a bacterial genome [39]. Generalised transduction occurs when 119 
bacteriophages in the lytic cycle incorporate sections of the DNA of the bacterial host 120 
during capsid synthesis. In specialised transduction, regions immediately flanking the 121 
integration site of a lysogenic phage are excised and packaged into the capsid [39]. 122 
Lateral transduction, in contrast, occurs when prophages initiate DNA replication 123 
while they are still integrated into the host. This process generates multiple copies of 124 
DNA before excision from the host genome occurs. Once excised, the DNA – which 125 
may contain both phage and the adjacent genes up to hundreds of kilobases in 126 
length – are packaged into new phage particles and transferred to other bacterial 127 
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strains [40]. The human gut contains an extensive community of bacteriophages 128 
[41,42] and significant numbers of ARG-carrying phages are present in the human 129 
gut and other environments [43]. The abundance of these ARG-carrying phages in 130 
the human gut increases upon antibiotic treatment [●44]. Experiments in mouse 131 
models have shown that transduction is a driving force behind genetic diversity in 132 
gut-colonising E. coli strains [●45] and can contribute to the emergence of drug 133 
resistance in gut bacteria [46]. However, the quantitative contribution of phages to 134 
the horizontal transfer of ARGs is still poorly understood. We foresee that novel 135 
methods to detect and quantify HGT in the gut (further outlined below) will be 136 
implemented to address this question. 137 
In conjugation, mobile genetic elements such as plasmids and integrative and 138 
conjugative elements (ICEs) are transferred from one bacterium to another [47]. 139 
Among conjugative elements, conjugative plasmids are arguably the most relevant 140 
for the spread of ARGs as they have the potential to carry multiple resistance genes, 141 
due to their substantial size (median of 90 kbp) and the common occurrence of one 142 
or more toxin-antitoxin modules which ensure that plasmids are retained within their 143 
microbial hosts [48]. In addition, conjugative plasmids frequently carry genes, other 144 
than ARGs, that contribute to microbial fitness, e.g. by coding for novel metabolic 145 
routes or tolerance to disinfectants or heavy metals. Antibiotic resistance 146 
determinants can thus be co-selected under a variety of conditions as they share a 147 
genetic platform with other fitness determinants [48]. Conjugation is a complex, 148 
multistage, and contact-dependent process where DNA is transported via a pilus 149 
between bacteria in close proximity to each other [49]. The gut, with its high density 150 
of bacterial cells and dense mucus layer, provides an environment conducive to 151 
conjugation. The spread of antibiotic resistance plasmids and ICEs has been 152 
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observed among commensals and opportunistic pathogens while colonising the 153 
human gut [50–52]. Notably, conjugative plasmids can provide the machinery 154 
allowing the mobilisation of DNA that is not self-transmissible, thus greatly increasing 155 
the potential for HGT of resistance determinants [53].   156 
 157 
Bioinformatic tools to study HGT in the gut 158 
The high-throughput sequencing of DNA isolated from microbial ecosystems, often 159 
referenced to as shotgun metagenomics, is widely used to study the microbial 160 
diversity of the human gut microbiome [54]. The Illumina DNA sequencing platform is 161 
most commonly used for shotgun metagenomic studies of the gut microbiome. The 162 
relatively short sequence reads generated by Illumina sequencers can be used to 163 
detect and quantify the abundance of ARGs in the human gut microbiome [55]. It is, 164 
however, difficult to resolve linkage of ARGs and MGEs as these elements are 165 
generally rich in DNA repeats that are difficult to resolve with short reads [56]. The 166 
advent of long-read technologies such as Oxford Nanopore and PacBio sequencing 167 
allows the reconstruction of genome and plasmid sequences from complex 168 
metagenomic samples [19]. Independent of the platform used for shotgun 169 
metagenomics, approaches based on DNA sequencing have long struggled to 170 
identify the microbial hosts of ARGs and to detect HGT events. Recently, advanced 171 
bioinformatic tools have been developed to address this issue (Table 1).  172 
Different approaches have been developed to identify HGT events in metagenomic 173 
sequencing data [●57]. These tools include MetaCHIP, which uses a combination of 174 
best-match and phylogenetic approaches to identify HGT candidates from genes that 175 
have a different taxonomic assignment to the contig or genome they have been 176 
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assembled into [58]. An additional method, MetaCherchant, has been developed 177 
which uses local de Bruijn graph assembly to uncover the wider context of ARGs. 178 
When metagenomes from a time series are compared, a change in gene context 179 
suggests that an HGT event has occurred [59]. A recently developed binning 180 
technique which utilises the methylation patterns of DNA, as determined by Oxford 181 
Nanopore and PacBio sequencing, has proven useful in linking MGEs to their host. 182 
Methylation motifs are given scores and DNA sequences from MGE and from 183 
bacterial genomes can be matched based on their methylation scores thus 184 
identifying the host of the MGE [●60]. If the same MGE is identified in multiple hosts 185 
then an HGT event may have occurred. However, purely metagenomic methods are 186 
still limited in their ability to accurately identify all HGT events, because the 187 
conjugative transfer of ARG-carrying plasmids between different microbial hosts 188 
cannot be resolved by DNA sequencing alone. For this reason, novel experimental 189 
approaches have been developed to characterise HGT in the gut microbiome (Table 190 
1; Figure 2). 191 
 192 
Novel experimental approaches to study HGT in the gut 193 
HGT has been studied in the human gut since the 1960s [61]. In these human 194 
challenge studies, bacteria capable of transferring DNA (‘donors’’) and recipient 195 
strains were administered to the host and transconjugants were then isolated by 196 
selective culture from the host faeces. However, these studies are fraught with 197 
ethical challenges as there is a risk that multidrug resistant donor strains or 198 
transconjugants colonize the gut of the volunteers, and thus animal models are more 199 
frequently used to study HGT in the gut (Figure 2A). More recently, culturing of 200 
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human faeces on selective media has identified novel hosts of ARGs, such as the 201 
vanB vancomycin resistance transposon in the gut commensals Eggerthella lenta 202 
and Clostridium innocuum [62], which can be transferred to the opportunistic 203 
pathogen E. faecium in the mouse gut [63]. These findings support the hypothesis 204 
that gut commensals act as a reservoir for ARGs. A drawback of these approaches 205 
is that they require the recipient cells to be cultured and while important advances 206 
have been made in the isolation of gut commensals [64], it remains technically 207 
challenging to systematically identify strains that acquire ARGs and uncover the 208 
hidden network of HGT in the gut.  209 
In recent years, novel techniques have been developed which allow the high-210 
throughput characterisation of HGT events in microbial communities. The inclusion 211 
of fluorescent markers on plasmids has enabled the use of technologies such as 212 
confocal fluorescence microscopy and Fluorescence Activated Cell Sorting (FACS) 213 
to uncover the host range of plasmids (Figure 2B). In one study, HGT events were 214 
identified by the use of plasmids that carry a green fluorescent protein gene (gfp) of 215 
which expression was controlled by a chromosomally encoded repressor. Upon 216 
conjugation of the plasmid to a new host, repression of gfp was lifted and 217 
transconjugants could be identified by their green fluorescence [65]. 218 
Transconjugants were then isolated using FACS and subsequently subjected to 16S 219 
rRNA gene sequencing to identify which hosts the plasmids had spread to. A 220 
drawback of this approach is that typically only one plasmid is examined at a time, 221 
which limits our understanding of the wider picture of HGT events within a 222 
microbiome. In addition, there is a distinct lack of genetic tools to perform these 223 
studies in microbial hosts other than model strains like E. coli MG1655.   224 
11 
Several techniques have been developed that physically link ARGs to their microbial 225 
hosts in microbiomes. These data can be used to elucidate the patterns of ARG 226 
dissemination in microbiomes (Figure 2C). In Emulsion, Paired Isolation, and 227 
Concatenation PCR (epicPCR), single microbial cells are encapsulated in 228 
polyacrylamide beads followed by a fusion PCR step within individual beads. This 229 
results in a concatemer of the targeted gene (e.g. an ARG) and the 16S rRNA gene, 230 
which serves as a phylogenetic marker [66]. The resulting fusion PCR amplicon can 231 
be sequenced using Illumina technology to identify the host(s) of the gene targeted 232 
in epicPCR. Recently, epicPCR has been used to determine the diversity of ARG 233 
hosts in wastewater [67]. 234 
Another technique that can be used to identify the bacterial hosts of ARGs is 235 
chromosome conformation capture (3C). During 3C, cells are incubated with 236 
formaldehyde to cross-link the DNA, followed by restriction digestion, ligation of the 237 
cross-linked DNA and finally reversal of the cross-linking [68]. Sequencing the 238 
resulting 3C library will then reveal cross-links between MGEs carrying ARGs and 239 
chromosomal DNA, thus allowing the host of the MGEs to be identified. 240 
Metagenomic 3C (meta3C) was performed on mouse gut microbiome samples to link 241 
phage sequences to their bacterial hosts [●69]. Recently, a derivative of 3C called 242 
Hi-C, which includes an additional step to enrich for ligated fragments of DNA, has 243 
been used to link ARGs to their bacterial hosts in a variety of complex samples. By 244 
performing Hi-C on a wastewater sample, the microbial hosts of ARGs and in situ 245 
host ranges of plasmids were assessed, where the authors found that the phylum 246 
Bacteroidetes was one of the most common reservoirs of ARGs in the sample [70]. 247 
Also using Hi-C data, in combination with long-read assembly, the microbial hosts of 248 
viruses and ARGs were linked in a cow rumen microbiome [●71]. Hi-C has similarly 249 
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been performed on human gut microbiome samples. In a pioneering study, an 250 
approximately 600-kbp megaplasmid was linked to several species in the order 251 
Clostridiales [72]. More recently, the transfer of accessory elements was tracked in 252 
two human stool samples collected 10 years apart using 3C, but the authors did not 253 
discuss linkage of ARGs to their microbial hosts [73]. While there has, thus far, been 254 
no extensive study using 3C or its derivatives to link ARGs to their host in a human 255 
gut microbiome sample, these studies have provided a foundation for the use of 256 
these novel techniques to study HGT in the gut.  257 
A recent study [●●74] described an elegant recorder for HGT events based on the 258 
ability of the CRISPR-Cas9 system to integrate fragments of invading DNA into the 259 
bacterial genome (Figure 2D). CRISPR-Cas9 is an adaptive immune system that 260 
bacteria use to defend against invasion by foreign DNA [75]. Invading DNA is 261 
incorporated into the bacterial genome at the CRISPR locus by the Cas1-Cas2 262 
complex in a process known as spacer acquisition. These sequences are 263 
subsequently transcribed and used to target the Cas9 nuclease to invading DNA 264 
which matches the spacer sequence [76]. To record HGT events, Munck and co-265 
workers engineered an E. coli strain containing a plasmid with the cas1-cas2 operon 266 
under the control of an inducible promoter to capture DNA sequences which have 267 
entered the cell. Sequencing of the CRISPR spacer regions was then used to not 268 
only identify HGT events but also the order in which the events occurred. When this 269 
system was applied to clinical faecal samples, it showed that HGT is frequent in the 270 
gut and that IncX-type plasmids transferred most actively [●●74]. This technique 271 
promises to uncover HGT events at an unprecedented resolution, but to unveil the 272 
full extent of the gut mobilome it will need to be adapted to function in bacteria which 273 
fall outside of the Enterobacteriaceae family. 274 
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 275 
Conclusions and future perspectives 276 
The human gut microbiome contains a wide variety of ARGs. Modern sequencing-277 
based and experimental technologies are uncovering the extent by which resistant 278 
genes spread between strains and species that inhabit the gut. Genes that confer 279 
resistance against clinically relevant antibiotics and are carried on mobile genetic 280 
elements that replicate in pathogens are considered to be an immediate threat to the 281 
successful treatment of clinical infections [77]. While bacteriophages can potentially 282 
mobilise any chromosomal gene or mutation, the conjugative spread of plasmids is 283 
still widely considered to be the most important way resistance genes can be 284 
transferred among bacteria.  285 
The observation that ARGs from opportunistic pathogens can also be found in the 286 
genomes of Gram-positive commensal bacteria [62,78] suggests that HGT of ARGs 287 
in the gut is pervasive, particularly among the Firmicutes. Carbapenemases and 288 
extended-spectrum beta-lactamases that are increasingly prevalent in the 289 
opportunistic pathogens E. coli and K. pneumoniae can readily spread among 290 
Proteobacteria in the gut [79,80] but HGT to other phyla have, to our knowledge, not 291 
been reported. The scarcity of HGT of resistance genes across phyla can be 292 
explained by the specific physiological contexts in which proteins conferring antibiotic 293 
resistance need to operate, which makes it unlikely that resistance genes can be 294 
functional, at a low biological cost, in phylogenetically disparate bacteria [●●81]. 295 
However, soil microcosm experiments have provided evidence that plasmids can 296 
spread, albeit infrequently, among diverse phyla [65]. As HGT is a common event in 297 
the gut microbiome [●●74], it is not unlikely that broad-host range MGEs carrying 298 
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resistance genes will start to disseminate across phyla, although intra-phylum HGT 299 
remains quantitatively more important. There is still a lack of knowledge on the 300 
conditions in the gut microbiome that favour HGT events, but inflammation of the 301 
host and the production of membrane-destabilizing agents by both the microbiota 302 
and the host have been proposed to promote HGT in the gut [82].  303 
Our improved understanding of HGT in the gut opens up avenues for novel 304 
interventions to minimise transfer of ARGs, e.g. by the conjugative delivery of 305 
CRISPR-Cas to selectively deplete strains carrying resistance genes [●83]. We 306 
envisage that the novel techniques reviewed here will aid in further elucidating the 307 
exchange networks of ARGs in the human gut. The information gleaned from these 308 
studies can then support the development of targeted approaches to control or 309 
reduce the number of antibiotic-resistant bacteria in the human gut, particularly in 310 
individuals that are at high risk of developing infections, such as neonates, the 311 
immunocompromised, and the elderly. 312 
  313 
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Table 322 












Identifies differences in taxonomic 
assignments between genes and 
the contig or genome they have 
been assembled into 
Detection of recent HGT 
events is challenging 
[58] 
MetaCherchant 
Uses local De Bruijn graph 
assembly to uncover wider context 
of ARGs 
HGT of high copy-number 
MGEs may be difficult to 
detect due to complexity of 
the assembly graph 
[59] 
Binning by DNA 
methylation 
DNA sequences from MGEs and 
bacterial genomes are matched 
based on their methylation 
High numbers of genomes in 

















Strains with MGEs are 
administered to a host and 
transconjugants are then isolated 
from faecal samples by culture  





methods to identify bacterial hosts 
of antibiotic resistance genes 
Laborious and technically 
challenging, particularly for 





Fluorescently-tagged plasmids are 
used to track the movement of 
plasmids in complex microbiomes 





Single microbial cells are captured 
in polyacrylamide beads, followed 
by fusion PCR on a target and the 
16S rRNA gene, and sequencing of 
the amplicon 
Targets only one gene per 
experiment; uses 16S rRNA 
gene as a low-resolution 
phylogenetic marker; 
requires multiple rounds of 






By physically cross-linking DNA 
inside microbial cells, and 
subsequent sequencing of the 
cross-linked DNA, the hosts of 
genes of interest are identified 
Requires high sequencing 
depth; can be difficult to 
accurately resolve hosts to 
strain- or species-level 
[●69,73] 
Hi-C 
Similar to meta3C but with an 
additional step to enrich for cross-




A CRISPR-based system that 
utilises the spacer acquisition 
process to record HGT events. 
Uniquely able to track transient 
HGT events. 
The system has presently 




Table 1. Summary of current approaches to study horizontal gene transfer in 324 
the gut microbiome. Bioinformatic approaches to identify HGT have recently been 325 
reviewed in [●57] and the tools highlighted here are a selection of those that have 326 
recently been developed. All bioinformatic tools listed in this table for detecting HGT 327 
17 
in metagenomes are reliant on accurate and contiguous metagenomic assembly. 328 
Ref: references. 329 
  330 
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Figure legends 331 
 332 
Figure 1. Mechanisms of horizontal gene transfer (HGT). 333 
Transformation: physiologically competent bacteria can take up naked DNA from 334 
the environment. Membrane vesicle fusion: 20-250 nm spherical, lipid bilayer-335 
enclosed vesicles can transport cargo between bacteria, including DNA. 336 
Transduction: genetic material can be transferred between donor and recipient 337 
bacteria via a bacteriophage intermediate. Conjugation: mobile genetic elements, 338 
such as plasmids, can transfer via a pilus formed between donor and recipient cells. 339 
The mechanisms of HGT illustrated in this figure can mediate the transfer of both 340 
chromosomal and extra-chromosomal DNA.  341 
 342 
Figure 2. Experimental approaches to study horizontal gene transfer (HGT) in 343 
the gut. 344 
Panel A: the use of culture-based animal models to study HGT. Laboratory animals 345 
are fed bacteria containing an antibiotic resistance gene (ARG)-plasmid and stool 346 
samples can then be cultured on antibiotic-containing media to isolate 347 
transconjugants. Panel B: fluorescent reporter systems to identify HGT events. A 348 
donor cell carries a green-fluorescent protein (GFP)-tagged plasmid and a repressor 349 
gene on the chromosome. GFP will only be expressed when the plasmid is 350 
transferred to another cell that does not contain the repressor and GFP-producing 351 
transconjugants can thus be isolated using fluorescence-activated cell sorting 352 
(FACS). Panel C: novel techniques for physically linking ARGs to their microbial 353 
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host. Emulsion, Paired Isolation, and Concatenation PCR (epicPCR) involves the 354 
encapsulation of single bacterial cells in polyacrylamide beads. After cell lysis, a 355 
PCR is performed in each bead individually. The PCR targets an ARG with custom 356 
primers where the reverse primer contains an overhang homologous to the 16S 357 
rRNA gene, of which another conserved region is targeted by a third primer. The 358 
resulting fusion PCR amplicon contains the ARG fused with the 16S rRNA gene of 359 
its host(s). Chromosome conformation capture approaches use formaldehyde to 360 
cross-link DNA inside cells. Cells are then lysed, followed by enzymatic digestion of 361 
the DNA, ligation of the cross-linked fragments, and finally removal of the cross-links, 362 
ultimately leaving linked DNA fragments that were in close physical proximity to each 363 
other. Panel D: CRISPR spacer acquisition as a tool for HGT detection. Using an 364 
engineered bacterial strain containing a plasmid with the cas1-cas2 operon, the 365 
sequences of DNA entering the cell are captured and incorporated into the CRISPR 366 
array. By sequencing the CRISPR array, HGT events can be observed, including the 367 
order in which they occurred. 368 
  369 
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